Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Waller

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biochemical Society Transactions|May 28, 2026
Dissecting conserved molecular mechanisms of biological toxin activity through CRISPR screeningMatthew A Waller, Tian Y D'Araujo, Christopher E Denes, et al.
Frontiers in Neuroscience|January 11, 2020
Developing Modern Pain TherapiesJohn Manion, Matthew A Waller, Teleri Clark, et al.
Trends in Biotechnology|March 16, 2024
CRISPR activation screens: navigating technologies and applicationsTeleri Clark, Matthew A Waller, Lipin Loo, et al.
Frontiers in Pharmacology|April 16, 2026
<i>Bothrops</i> venom variation drives niche-specific pharmacology through Ca<sup>2+</sup> signalling and membrane damageLachlan A Bourke, Julien Slagboom, Matthew A Waller, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 28, 2025
Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screensTali S Skipper, Kristie-Ann Dickson, Christopher E Denes, et al.
Nature Medicine|February 20, 2019
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophyChristopher E Nelson, Yaoying Wu, Matthew P Gemberling, et al.
Nature Communications|March 15, 2020
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skippingPeter Gee, Mandy S Y Lung, Yuya Okuzaki, et al.
Plos Biology|February 9, 2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programsLipin Loo, Matthew A Waller, Cesar L Moreno, et al.
Cell Death Discovery|April 2, 2026
Correction: The cytotoxicity of gomesin peptides is mediated by the glycosphingolipid pathway and lipid-cholesterol interactionsIsabel Fernandez-Carrasco, Javier Moral-Sanz, Sergey Kurdyukov, et al.
Cell Death Discovery|November 21, 2025
The cytotoxicity of gomesin peptides is mediated by the glycosphingolipid pathway and lipid-cholesterol interactionsIsabel Fernandez-Carrasco, Javier Moral-Sanz, Sergey Kurdyukov, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biochemical Society Transactions|May 28, 2026
Dissecting conserved molecular mechanisms of biological toxin activity through CRISPR screeningMatthew A Waller, Tian Y D'Araujo, Christopher E Denes, et al.
Frontiers in Neuroscience|January 11, 2020
Developing Modern Pain TherapiesJohn Manion, Matthew A Waller, Teleri Clark, et al.
Trends in Biotechnology|March 16, 2024
CRISPR activation screens: navigating technologies and applicationsTeleri Clark, Matthew A Waller, Lipin Loo, et al.
Frontiers in Pharmacology|April 16, 2026
<i>Bothrops</i> venom variation drives niche-specific pharmacology through Ca<sup>2+</sup> signalling and membrane damageLachlan A Bourke, Julien Slagboom, Matthew A Waller, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 28, 2025
Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screensTali S Skipper, Kristie-Ann Dickson, Christopher E Denes, et al.
Nature Medicine|February 20, 2019
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophyChristopher E Nelson, Yaoying Wu, Matthew P Gemberling, et al.
Nature Communications|March 15, 2020
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skippingPeter Gee, Mandy S Y Lung, Yuya Okuzaki, et al.
Plos Biology|February 9, 2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programsLipin Loo, Matthew A Waller, Cesar L Moreno, et al.
Cell Death Discovery|April 2, 2026
Correction: The cytotoxicity of gomesin peptides is mediated by the glycosphingolipid pathway and lipid-cholesterol interactionsIsabel Fernandez-Carrasco, Javier Moral-Sanz, Sergey Kurdyukov, et al.
Cell Death Discovery|November 21, 2025
The cytotoxicity of gomesin peptides is mediated by the glycosphingolipid pathway and lipid-cholesterol interactionsIsabel Fernandez-Carrasco, Javier Moral-Sanz, Sergey Kurdyukov, et al.
Pageof 1